Sign in
4

Changes in Ownership

Evofem Biosciences, Inc. Filed Acc 0001209191-15-081396

Chief Scientific Officer sold 6,098 shares at $8.30 ($50,619)

  • Chief Scientific Officer acquired 6,098 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Locke Kenneth W Chief Scientific Officer 2015-11-18 Option exercise +6,098 $8.30 $50,619 6,391 D
Locke Kenneth W Chief Scientific Officer 2015-11-18 Sale −6,098 $8.30 $50,619 293 D
Derivatives
Locke Kenneth W Chief Scientific Officer 2015-11-18 Option exercise · Stock Option (Right to Buy) −4,093 23,191 D
Locke Kenneth W Chief Scientific Officer 2015-11-18 Option exercise · Stock Option (Right to Buy) −2,005 11,366 D
Open-market sales · 6,098 sh · avg $8.30 · $50,619
Loading xslF345X03/doc4.xml…